Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 121,328 shares at $23.11 ($2.8M) on 2022-12-21, disclosed to the SEC on 2022-12-21.
Open-market sale of $2.8M COLL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.04 | 3,606 | $83K | 3.0% |
| 2 | $23.04 | 3,606 | $83K | 3.0% |
| 3 | $23.08 | 33,758 | $779K | 27.8% |
| 4 | $23.08 | 33,758 | $779K | 27.8% |
| 5 | $23.11 | 46,600 | $1.1M | 38.4% |
| Total | $23.09 avg | 121,328 |
| $2.8M |
| 100% |
| Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |
| COLL | SELL | 2020-05-15 | $804K | — | Filing → |